IT vs SER · P/E 16, rev $6.27B vs rev $56.0K
Gartner Inc (IT) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
Gartner Inc (IT) is a information technology services company listed on US.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
IT currently screens at market cap $11.03B and trailing P/E 16.3. SER currently screens at market cap $29.7M.
Not investment advice. Open the IT and SER stock pages for the full models.
Not investment advice.